RHEB and diabetes mellitus: Diabetes increases mTOR activity in the kidney, probably due to reduced AMP-activated protein kinase signaling [100] or decreased interaction between glyceraldehyde 3-phosphate dehydrogenase and Rheb [106], each of which promotes mTOR activation by Rheb [107].